» Articles » PMID: 10647992

CD40-CD40 Ligand

Overview
Journal J Leukoc Biol
Date 2000 Jan 27
PMID 10647992
Citations 507
Authors
Affiliations
Soon will be listed here.
Abstract

CD40 is a cell surface receptor that belongs to the tumor necrosis factor-R (TNF-R) family, and that was first identified and functionally characterized on B lymphocytes. Its critical role in T cell-dependent humoral immune responses was demonstrated by patients with the hyper-IgM syndrome, as well as by gene targeting in mice. However, in recent years it has become clear that CD40 is expressed much more broadly, including expression on monocytes, dendritic cells, endothelial cells, and epithelial cells. In addition, the CD40-ligand (CD40-L/CD154), a member of the TNF family, is also expressed more widely than activated CD4+ T cells only. Therefore it is now thought that CD40-CD40-L interactions play a more general role in immune regulation. Collectively these studies have culminated in pre-clinical and clinical studies that are in progress. This article reviews recent developments in this field of research, with main emphasis on (1) structure and expression of CD40 and its ligand; (2) CD40 signal transduction; (3) in vitro function of CD40 on different cell types; and (4) in vivo functions of CD40/CD40-L interactions.

Citing Articles

DNA-PK inhibition enhances gene editing efficiency in HSPCs for CRISPR-based treatment of X-linked hyper IgM syndrome.

Pugliano C, Berger M, Ray R, Sapkos K, Wu B, Laird A Mol Ther Methods Clin Dev. 2025; 32(3):101297.

PMID: 40012884 PMC: 11863497. DOI: 10.1016/j.omtm.2024.101297.


Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma.

David P, Kouhestani D, Hansen F, Paul S, Czubayko F, Karabiber A Int J Mol Sci. 2025; 26(4).

PMID: 40003965 PMC: 11854914. DOI: 10.3390/ijms26041500.


CD40 Ligand Potentiates Immunogenecity of Subunit Vaccine Candidate in a Murine Model.

Shu J, Li G, Shu J, Feng H, He Y Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852152 PMC: 11763752. DOI: 10.3390/cimb47010037.


CD154 blockade effectively controls antibody-mediated rejection in highly sensitized nonhuman primate kidney transplant recipients.

Anwar I, DeLaura I, Ladowski J, Schiliro D, Gao Q, Manook M Sci Transl Med. 2025; 17(779):eadn8130.

PMID: 39742504 PMC: 11797747. DOI: 10.1126/scitranslmed.adn8130.


Causality between immunocytes and polymyositis: A Mendelian randomization analysis.

Yang N, Li C, Liu R, Qi X, Qian X Medicine (Baltimore). 2024; 103(43):e40254.

PMID: 39470507 PMC: 11521033. DOI: 10.1097/MD.0000000000040254.